About Vitaflo
Our dedicated experts have over 30 years’ experience in producing specialist nutritional products. Working in partnership with world key opinion leaders and patients, Vitaflo’s aim is to create products that combine the best of cutting edge research with the lifestyle demands of modern living, ensuring the most acceptable products are available for the patient.
Inborn Errors of Metabolism
Pediatric Kidney Disease
There are two types of kidney disease; Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD). Provision of adequate nutrition is vital in the management of children with kidney disease to enable normal growth and development1. Dietary management also aims to avoid the accumulation of toxic metabolites, reduce morbidities such as renal bone disease and ultimately improve quality of life2.
1. KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 Update. 2009.
2. Royle J. Chapter 12: Kidney Disease. In: Shaw V, editor. Clinical Paediatric Dietetics. 4: John Wiley & Sons Ltd.; 2015. p. 242-81
Ketogenic Diet
Epilepsy is a disease of the brain which is characterised by recurrent seizures. It is the most prevalent neurological disorder aside from migraines, affecting approximately 50-60 million people worldwide1. Seizures are diagnosed and classified by strict criteria as defined by International League Against Epilepsy (ILAE) 2. Whilst pharmacological treatment is successful for many, approximately 30% of cases fail to respond to two or more anti-epileptic drugs (AED’s)3, 4. This is termed ‘drug resistant epilepsy’5. For these individuals, interventions such as surgery and vagal nerve stimulation may be indicated and beneficial, however, both are invasive, carry the risk of complications and are not suitable for everyone.
Vitaflo have developed a number of products that can be used as part of the ketogenic diet, which help aid compliance and make the diet more manageable.
1.Megiddo I, Colson A, Chisholm D, Dua T, Nandi A, Laxminarayan R. Health and economic benefits of public financing of epilepsy treatment in India: An agent‐based simulation model. Epilepsia. 2016;57(3).
2. Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475-82.
3. Granata T, Marchi N, Carlton E, Ghosh C, Gonzalez-Martinez J, Alexopoulos AV, et al. Management of the patient with medically refractory epilepsy. Expert review of neurotherapeutics. 2009;9(12):1791-802.
4. Martin K, Jackson CF, Levy RG, Cooper PN. Ketogenic diet and other dietary treatments for epilepsy. The Cochrane database of systematic reviews. 2016;2:CD001903.
Healthcare Professional Education
Get in touch